Stage I-III Resectable NSCLC

Revised: November 6, 2026

Note: Click on a trial title for more information.

Key:

  • Open
  • Thoracic

    Stage I-III Resectable NSCLC

    • VICCTHO2292

      NeoCOAST-2: Ph II Study of Neoadjuvant & Adjuvant Tx in Resectable, Early-Stage NSCLC

      • - Newly diagnosed and previously untreated patients with resectable stage IIA - IIIB NSCLC
        - Patients with N2 disease are eligible if they are candidates for lobectomy, sleeve resection, or bilobectomy
        - Patients with N3 disease are excluded